OCULAR MELANOMA
Clinical trials for OCULAR MELANOMA explained in plain language.
Never miss a new study
Get alerted when new OCULAR MELANOMA trials appear
Sign up with your email to follow new studies for OCULAR MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise in High-Risk eye cancer trial
Disease control CompletedThis study tested a drug called darovasertib in 15 people with a high-risk eye cancer called uveal melanoma. Participants took the drug for up to 4 weeks before having their eye removed, and some continued treatment for 6 months after surgery. The main goal was to see if the drug…
Matched conditions: OCULAR MELANOMA
Phase: PHASE2 • Sponsor: St Vincent's Hospital, Sydney • Aim: Disease control
Last updated May 17, 2026 01:00 UTC
-
Immune cell therapy shows promise for Hard-to-Treat melanoma
Disease control CompletedThis early-phase study tested a new treatment called TBio-4101 for people with advanced melanoma that did not respond to standard therapies. The treatment uses a patient's own immune cells (TILs) that are grown in a lab and given back after chemotherapy and a drug called IL-2. Th…
Matched conditions: OCULAR MELANOMA
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New combo therapy shows promise for brain metastases
Disease control CompletedThis early-stage study tested a combination of an immunotherapy drug (pembrolizumab) and precise radiation (stereotactic radiosurgery) in 25 people with melanoma or lung cancer that had spread to the brain. The main goal was to check for serious side effects. The approach aims to…
Matched conditions: OCULAR MELANOMA
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Scientists decode DNA of rare eye tumors to unlock new treatments
Knowledge-focused CompletedThis study looked at the DNA of eye cancers (ocular melanoma) from 58 patients to find genetic changes that cause the cancer to grow and spread. By comparing samples taken at different times and from different parts of the same tumor, researchers aim to understand how these cance…
Matched conditions: OCULAR MELANOMA
Sponsor: The Wellcome Sanger Institute • Aim: Knowledge-focused
Last updated May 11, 2026 20:39 UTC